Literature DB >> 16894362

CYP19A1 genetic polymorphisms may be associated with obesity-related phenotypes in Chinese women.

J-R Long1, X-O Shu, Q Cai, W Wen, N Kataoka, Y-T Gao, W Zheng.   

Abstract

OBJECTIVE: To examine the relationship between genetic polymorphisms of the CYP19A1 gene and obesity-related phenotypes, body mass index (BMI) and waist-to-hip ratio (WHR).
SUBJECTS: In total, 1241 Chinese women, who were recruited as community controls for a population-based case-control study of breast cancer.
METHODS: Nineteen haplotype tagging single nucleotide polymorphisms (htSNPs) in four haplotype blocks were genotyped.
RESULTS: Significant associations were observed for WHR at three SNPs that are located in haplotype block 1, including rs2445765, rs1004984 and rs1902584 (P=0.05, 0.04 and 0.01, respectively). Women, particularly premenopausal women, who carried the minor allele at any of these SNPs, had higher WHR than those without it. Of these three SNPs, the strongest association was observed at rs1902584, which is the closest to Promoter I.4, the major promoter for adipose tissue. Haplotype analyses indicated an association between the haplotype TCCAT in block 1 and WHR with a P-value of 0.02.
CONCLUSION: These results suggested that CYP19A1 genetic polymorphisms may be associated with the risk of obesity among Chinese women, especially among premenopausal women. The CYP19A1 protein (aromatase) plays a critical role in estrogen biosynthesis and thus affects body fat distribution and regulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16894362     DOI: 10.1038/sj.ijo.0803439

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  8 in total

1.  The role of DENND1A and CYP19A1 gene variants in individual susceptibility to obesity in Turkish population-a preliminary study.

Authors:  Ela Kadioglu; Beril Altun; Çağrı İpek; Esra Döğer; Aysun Bideci; Hadi Attaran; İsmet Çok
Journal:  Mol Biol Rep       Date:  2018-09-19       Impact factor: 2.316

2.  Genetic and genomic insights into age at natural menopause.

Authors:  Francisco Jesus Moron; Agustin Ruiz; Jose Jorge Galan
Journal:  Genome Med       Date:  2009-08-06       Impact factor: 11.117

3.  Interaction of soy food and tea consumption with CYP19A1 genetic polymorphisms in the development of endometrial cancer.

Authors:  Wang Hong Xu; Qi Dai; Yong Bing Xiang; Ji Rong Long; Zhi Xian Ruan; Jia Rong Cheng; Wei Zheng; Xiao Ou Shu
Journal:  Am J Epidemiol       Date:  2007-09-07       Impact factor: 4.897

4.  Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women.

Authors:  Hui Cai; Xiao Ou Shu; Kathleen M Egan; Qiuyin Cai; Ji-Rong Long; Yu-Tang Gao; Wei Zheng
Journal:  Pharmacogenet Genomics       Date:  2008-08       Impact factor: 2.089

5.  Variants in hormone biosynthesis genes and risk of endometrial cancer.

Authors:  Sara H Olson; Irene Orlow; Sharon Bayuga; Camelia Sima; Elisa V Bandera; Katherine Pulick; Shameka Faulkner; Diana Tommasi; Daniel Egan; Pampa Roy; Homer Wilcox; Ali Asya; Ippolito Modica; Haider Asad; Robert Soslow; Ann G Zauber
Journal:  Cancer Causes Control       Date:  2008-04-25       Impact factor: 2.506

6.  Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China.

Authors:  Chu Chen; Lori C Sakoda; Jennifer A Doherty; Melissa M Loomis; Sherianne Fish; Roberta M Ray; Ming Gang Lin; Wenhong Fan; Lue Ping Zhao; Dao Li Gao; Helge Stalsberg; Ziding Feng; David B Thomas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

7.  Estrogen and progesterone-related gene variants and colorectal cancer risk in women.

Authors:  Jennifer H Lin; JoAnn E Manson; Peter Kraft; Barbara B Cochrane; Marc J Gunter; Rowan T Chlebowski; Shumin M Zhang
Journal:  BMC Med Genet       Date:  2011-05-31       Impact factor: 2.103

8.  A novel resveratrol analog PA19 attenuates obesity‑induced cardiac and renal injury by inhibiting inflammation and inflammatory cell infiltration.

Authors:  Wenxin Zhang; Hongjin Chen; Chuchu Sun; Beibei Wu; Bin Bai; Hui Liu; Xiaoou Shan; Guang Liang; Yali Zhang
Journal:  Mol Med Rep       Date:  2019-04-12       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.